| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy |
| 08/01/2002 | US20020103149 An isolated nucleic acid molecule encoding a novel varient of vascular endothelial growth factor; vectors and host cells and reactive antibodies; controlling neovascularization; antitumor, - carcinogenic agents |
| 08/01/2002 | US20020103148 Vectors comprising SAR elements |
| 08/01/2002 | US20020103136 Conjugates useful in the treatment of prostate cancer |
| 08/01/2002 | US20020103134 Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
| 08/01/2002 | US20020103130 Amino acid sequence RX1ETX2WX3 (SEQ ID NO: ) wherein X1, X2 and X3 are any amino acid |
| 08/01/2002 | US20020103129 Small peptides having anti-angiogenic and endothelial cell inhibition activity |
| 08/01/2002 | US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103122 Methods of treatment and prevention of restenosis |
| 08/01/2002 | US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell |
| 08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
| 08/01/2002 | US20020103114 Administering therapeutically effective amount of bactericidal/permeability-increasing protein product to a human suffering from meningococcemia |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020103104 Administering to individual a antibacterially effective amount of an antagonist that inhibits or an agonist that activates an activity of a signal recognition particle polypeptide |
| 08/01/2002 | US20020102732 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/01/2002 | US20020102730 Expression system for factor VIII |
| 08/01/2002 | US20020102728 Generating cells for treating osteoporosis and osteoarthritis; obtain cells, transform cell with vector coding bone morphogenic protein, recover transformed cells, culture cells |
| 08/01/2002 | US20020102725 Nucleic acid encoding ion transporter component protein |
| 08/01/2002 | US20020102724 Novel hematopoietic genes and polypeptides |
| 08/01/2002 | US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 08/01/2002 | US20020102721 Diagnosing cancer; obtain sample, monitor concentration tumor suppressor proteins, compare to control, amplified concentration indicate cancer |
| 08/01/2002 | US20020102714 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/01/2002 | US20020102711 Polypeptide for use in the treatment of cancer and immunological |
| 08/01/2002 | US20020102710 Polypeptide for use in the treatment of cancer, autoimmune diseases and inflammation |
| 08/01/2002 | US20020102709 Polypeptide for use in tissue regeneration |
| 08/01/2002 | US20020102708 SH3-containing proteins |
| 08/01/2002 | US20020102706 Polypeptide for use in treatment of cell proliferation disorders |
| 08/01/2002 | US20020102705 Regulatory sequences of the mouse villin gene - use in transgenesis |
| 08/01/2002 | US20020102704 Testis specific glycoprotein zpep10 |
| 08/01/2002 | US20020102703 Kunitz domain polypeptide zkun10 |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102700 metK |
| 08/01/2002 | US20020102697 Genes encoding exopolysaccharide production |
| 08/01/2002 | US20020102695 Transcription factor stress-related proteins and methods of use in plants |
| 08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102679 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/01/2002 | US20020102678 Nucleotide sequences for use in detection of antibiotic resistant microorganism |
| 08/01/2002 | US20020102677 KCNQ5, a novel potassium channel |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102670 DNA coding for protein which confers on bacterium Escherichia coli resistance to L-homoserine, and method for producing L-amino acids |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102664 Nucleic acids coding enzymatic polypeptide for use in the generation of amino acids for use in animal nutrients |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102655 Simultaneous expression of both the heterologous protein, including functional membrane proteins, and a means for compartmentalizing or sequestering of the protein |
| 08/01/2002 | US20020102653 DNA coding for human cell surface antigen |
| 08/01/2002 | US20020102652 Polypeptide for use in the diagnosis, prevention and treatment of tumors and autoimmune diseases |
| 08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis |
| 08/01/2002 | US20020102646 Nucleotide sequences coding preferential protein for use in treating tumors |
| 08/01/2002 | US20020102644 Pharmaceutical compositions comprising herpes virus entry receptor protein |
| 08/01/2002 | US20020102643 Dorsal tissue affecting factor and compositions |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102641 Oncogenic osteomalacia-related gene 1 |
| 08/01/2002 | US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer |
| 08/01/2002 | US20020102639 Evi27 gene sequences and protein encoded thereby |
| 08/01/2002 | US20020102638 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases, genetic disorders and cancer |
| 08/01/2002 | US20020102637 Peptides for use in human therapeutics and diagnostics associated with pancreatic defects |
| 08/01/2002 | US20020102636 Promoter can regulate gene expression under various carbohydrate conditions; vector for transformation of a foreign gene or R. oryzae |
| 08/01/2002 | US20020102634 Human stanniocalcin-alpha |
| 08/01/2002 | US20020102633 Polypeptide for use in the treatment bone disorders and osteoarthritis |
| 08/01/2002 | US20020102628 Catabolite repression control (Crc) gene and pseudomonas virulence |
| 08/01/2002 | US20020102622 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 08/01/2002 | US20020102620 Immunoglobulins for use in the diagnosis and detection parasites |
| 08/01/2002 | US20020102618 Drosophila derived receptors of the steroid receptor superfamily |
| 08/01/2002 | US20020102616 Islet cell antigen 1851 |
| 08/01/2002 | US20020102615 Use in diagnosis of cell proliferative disorders such as cancer |
| 08/01/2002 | US20020102614 Detecting muscular disorder in humans; obtain sample tissue, measure zinc finger proteins, compare to control, evaluate for muscular disorder |
| 08/01/2002 | US20020102607 Peptide for use in the treatment of pain, stroke, nervous system disorders, multiple sclerosis, Huntington's chorea, food poisoning, cardiovascular disorders, drug addiction, muscular disorders, epilepsy |
| 08/01/2002 | US20020102604 Full-length human cDNAs encoding potentially secreted proteins |
| 08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/01/2002 | US20020102602 Polypeptide for use as an antitumor agent |
| 08/01/2002 | US20020102585 Prostate growth-associated membrane proteins |
| 08/01/2002 | US20020102576 Method of diagnosing pulmonary hypertension |
| 08/01/2002 | US20020102573 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects |
| 08/01/2002 | US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies |
| 08/01/2002 | US20020102562 Recombinant CMV neutralizing proteins |
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 08/01/2002 | US20020102551 Polypeptide; for use in diagnosis, prevention and treatment of nervous system and cell proliferative disorders |
| 08/01/2002 | US20020102546 Nucleic acid encoding an avian E.coli iss polypeptide and methods of use |
| 08/01/2002 | US20020102543 Nucleotide sequences for use as a diagnostic tools in genome analysis |
| 08/01/2002 | US20020102542 Polypeptide for use in the treatment of cancer, autoimmune and viral diseases |
| 08/01/2002 | US20020102541 Determination of genetic sex in equine species by analysis of y-chromosomal dna sequences |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102539 Nucleic acid coding polypeptide for use in cancer therapy |
| 08/01/2002 | US20020102538 Suppressor of HIV replication and transcription |
| 08/01/2002 | US20020102537 Retroviral production |
| 08/01/2002 | US20020102536 Preparation of human or animal herpesviruses |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102317 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 08/01/2002 | US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine |
| 08/01/2002 | US20020102273 Vaccines to protect animals from disease, particularly from disease caused by protozoan parasites such as Toxoplasma gondii, helminth parasites, ectoparasites, fungi, bacteria, or viruses |
| 08/01/2002 | US20020102271 Target of RNAIII activating protein (TRAP) |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule |
| 08/01/2002 | US20020102267 CLASP-5 transmembrane protein |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |